drug resistant tuberculosis การใช้

• In recent years drug resistant tuberculosis testing has shown a lot of progress.
• A number of medications are being studied for multi drug resistant tuberculosis including : bedaquiline and delamanid.
• She came to the United States 6 years after she first started caving and studied drug resistant tuberculosis
• Drug-resistant malaria is present in neighbouring countries while multi-drug resistant tuberculosis bacilli has spread worldwide.
• Drug resistant tuberculosis runs rampant through the prison populations and prisoners are served three meals a day of watery slop.
• Other activities have involved combating counterfeit medicines, condemning the stigma associated with mental illness, multi drug resistant tuberculosis and tobacco.
• Tuberculosis has been an ever-present concern within the Russian prison system, and recently a new infectious threat has emerged : multi-drug resistant tuberculosis ( MDR-TB ).
• Lilly's President and Chief Executive, Sidney Taurel, told reporters the company will make a US $ 70 million contribution over four years to programs tackling multi-drug resistant tuberculosis, or MDR-TB.
• On December 28, 2012 the U . S . Food and Drug Administration ( FDA ) approved bedaquiline ( marketed as Sirturo by Johnson & Johnson ) to treat multi-drug resistant tuberculosis, the first new treatment in 40 years.
• Today India's TB control program needs to update itself with the international TB guidelines as well as provide an optimal anti TB treatment to the patients enrolled under it or it will land up being another factor in the genesis of drug resistant tuberculosis.
• The company will team up with drug companies in developing countries, the World Health Organization and the U . S . Centers for Disease Control to tackle multi-drug resistant tuberculosis, or MDR-TB . The contribution would be given over four years, he said.
• It was formally approved for use by the U . S . Food and Drug Administration ( FDA ) for use in tuberculosis ( TB ) treatment, as part of a fast-track approval for use only in cases of multidrug-resistant tuberculosis, and the more resistant extensively drug resistant tuberculosis.